In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...

Greenlight Capital funds returned -3.6% in Q3 2025, net of fees and expenses, compared to 8.1% for the S&P 500 index, ...

Business and technology insights company Gartner today announced its list of  top strategic technology trends that organisations need to explore in 2026. “Technology leaders face a pivotal year in ...

Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...

By Ebele Orakpo While some believe that Genetic Modification is the best way to achieve food sufficiency, others call it agro-terrorism/bioterrorism; Russia’s President Vladimir Putin was quoted as ...

Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...